Suchergebnisse - "Altorki, N"

PubPharm (96)

1

Overall survival with adjuvant atezolizumab after chemotherapy in resected stage II-IIIA non-small-cell lung cancer (IMpower010) : a randomised, multicentre, open-label, phase III trial

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2023

von Felip, E. | Altorki, N. | Zhou, C. | +13

CommentIn: Ann Oncol. 2023 Oct;34(10):829-830. - PMID 37777306

2

Variation by stage in the effects of prediagnosis weight loss on mortality in a prospective cohort of esophageal cancer patients

enthalten in: Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus | 2017

von Shen, S. | Araujo, J. | Altorki, N. | +6

3

Prediagnosis aspirin use and outcomes in a prospective cohort of esophageal cancer patients

enthalten in: Therapeutic advances in gastroenterology | 2016

von Araujo, J. | Altorki, N. | Sonett, J. | +5

4

Phase I study of epigenetic priming with azacitidine prior to standard neoadjuvant chemotherapy for patients with resectable gastric and esophageal adenocarcinoma

enthalten in: Clinical cancer research | 2016

von Schneider, B. | Shah, M. | Klute, K. | +12

5

Prediagnosis aspirin use and outcomes in a prospective cohort of esophageal cancer patients

enthalten in: Therapeutic advances in gastroenterology | 2016

von Araujo, J. | Altorki, N. | Sonett, J. | +5

6

429TiP IMpower010: A Phase III trial investigating atezolizumab (atezo) vs best supportive care (BSC) after adjuvant chemotherapy (chemo) in patients (pts) with completely resected NSCLC

enthalten in: Annals of oncology | 2016

von Zhou, C. | Altorki, N. | Valliéres, E. | +7

7

Cigarette smoke mediates epigenetic repression of miR-217 during esophageal adenocarcinogenesis

enthalten in: Oncogene | 2015

von Xi, S. | Inchauste, S. | Guo, H. | +15

8

Cigarette smoke mediates epigenetic repression of miR-217 during esophageal adenocarcinogenesis

enthalten in: International journal of pharmaceutical medicine | 2015

von Xi, S. | Inchauste, S. | Guo, H. | +15

9

Adjuvant Erlotinib (E) Versus Placebo (P) for Completely Resected Stage IB-IIIA EGFR-Positive (IHC/FISH) Non-Small Cell Lung Cancer (NSCLC): RADIANT Results

enthalten in: International journal of radiation oncology, biology, physics | 2014

von Altorki, N. | O'brien, M. | Eberhardt, W. | +6

10

International Association for the Study of Lung Cancer Computed Tomography Screening Workshop 2011 report

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2012

von Field, J. | Smith, R. | Aberle, D. | +95

CommentIn: J Thorac Oncol. 2012 May;7(5):943-4. - PMID 22722800

1
2
3
4
5
6
7
8
9
10
Nächster »
[10]